Blog

What Is Immunotoxicity and Why It Matters for Preclinical Drug Safety Immunotoxicity refers to any adverse effect a compound has on the structure or function of the immune system, whether or not that compound was designed to act on immunity at all. The immune system is, in fact, one of the common targets of both […]

Batten Disease (CLN3): A High-Unmet-Need Rare Neurodegenerative Disorder Driving Early Drug Discovery Investment CLN3, or Batten disease, is a rare childhood-onset neurodegenerative disorder caused by a ~1 kb deletion in the CLN3 gene, precisely on exons 7 and 8 on chromosome 16p11.2., predicted to result in a truncated protein. It is the most common subtype […]

What Is Nephrotoxicity and Why Drug-Induced Kidney Damage Goes Undetected Nephrotoxicity refers to kidney damage caused by exposure to chemical substances, including therapeutic drugs. The kidneys are particularly vulnerable because their role in filtering, concentrating, and excreting xenobiotics exposes tubular cells to high local concentrations of potentially toxic substances. Drug-induced nephrotoxicity causes approximately 20% of […]

DILI is a top cause of drug failure. Zebrafish hepatotoxicity assays detect liver toxicity earlier and more accurately than traditional preclinical models.

Zebrafish subchronic toxicity testing meets REACH requirements. Early-life stage fish studies deliver growth, reproduction and organ-level data — with lower costs and animal use.

Detect ototoxicity earlier with zebrafish lateral line assays. Screen aminoglycoside and cisplatin hair cell damage before rodent ABR studies at scale.

Improve translatability in preclinical research using predictive in vivo models to reduce clinical failure and strengthen early drug development decisions.

High-throughput screening in early drug discovery: when to integrate in vivo models to improve candidate selection and reduce preclinical risk.

Each year, tens of thousands of fish and other aquatic vertebrates are used in regulatory ecotoxicity studies across Europe alone. As scientific advances and regulatory pressure converge to reduce animal use in chemical safety testing, the industry is undergoing a directional shift to progressively expand the use of new approach methodologies (NAMs). The Need for […]

Zebrafish immunology models enable in vivo analysis of immune responses and inflammation, advancing drug discovery with scalable assays and translational insights.

Scientific analysis of animal testing pros and cons in preclinical drug development, including alternatives, 3Rs strategy, and translational impact.

How can genetic testing results be functionally validated in vivo to confirm variant pathogenicity in precision medicine?

Zebrafish models enable high-throughput screening of diabetic retinopathy, combining advanced phenotypic readouts and drug discovery efficiency.

Zebrafish models enable cost-effective, high-throughput screening of metabolic diseases for accelerated preclinical drug discovery.

Zebrafish-based bioimaging enables real-time in vivo visualization of organ-level drug effects using automated, high-throughput platforms.

Behavioral phenotyping in zebrafish assesses CNS drug effects through high-throughput screening and predictive preclinical insights

How zebrafish models are advancing microbiome studies, including germ-free models and gut development insights for translational research.

How zebrafish models support retinal repair studies and preclinical research into stem-cell-based eye therapies.

How zebrafish neurological models bridge in vitro and mammalian systems to enable high-throughput, functional disease modeling for early-stage drug discovery.

How to validate AI-driven drug discovery predictions using zebrafish models with in vivo precision, speed, and biological insight.

Why zebrafish male vs female differences impact in drug discovery. Improve preclinical efficacy and safety with sex-aware zebrafish models.

Zebrafish efficacy assays unlock therapeutic potential in drug discovery. Explore applications in cancer research, neurology, and regenerative medicine.

Zebrafish neurotoxicity screening helps predict drug safety, identifying neurotoxicity symptoms, risk factors, and effects with precise in vivo models.

How zebrafish enhance cardiotoxicity screening, improve early detection of cardiac risk, and support safer drug development in preclinical studies.

Good Laboratory Practices (GLP) ensure reliable preclinical research, meet FDA standards, and strengthen data integrity in drug development.

Clinical trial phases and FDA approval in drug development. Understand timelines, phase differences, and key regulatory milestones in one clear guide.

Developmental neurotoxicity insights using zebrafish behavioral assays: discover how this in vivo model advances preclinical drug discovery decisions.

Zebrafish cancer models enable in vivo drug screening and tumor tracking, helping develop targeted anticancer therapies in oncology drug development.

Developmental Toxicity of PROTACs: Explore in vivo screening strategies, safety concerns, and regulatory insights to support safer drug development.

Zebrafish toxicity screening helps accelerate drug discovery with early safety insights. Explore 3 fast, cost-effective strategies to de-risk compounds.

Exploring how zebrafish models accelerate neurological drug discovery through high-throughput screening and in vivo insights

Discover how zebrafish models of human disease are revolutionizing research in neurology, oncology, infections, and rare disorders with real-world breakthroughs.

Discover how zebrafish are advancing modeling human diseases in neurology, cardiology, oncology, and ophthalmology.

How zebrafish enhance lead optimization, ADME prediction, and drug discovery efficiency in early-stage development.

Learn how zebrafish revolutionize pharmaceutical toxicology by enabling high-throughput environmental and human risk assessments.

Learn about environmental risk assessment (ERA) for medicinal products, including PBT/vPvB evaluations and the role of zebrafish in them.

Developmental toxicity screening using zebrafish offers a predictive, ethical, and cost-effective in vivo model aligned with ICH S5 (R3) standards.

Explore zebrafish disease models built with CRISPR, Tol2, and morpholinos for precise genetic research.

Reproductive toxicity testing with zebrafish provides fast, predictive insights for early-stage drug development aligned with ICH guidelines.

Explore non-clinical safety assessments for new drugs, from ICH guidelines to zebrafish models in preclinical toxicology.

Discover why zebrafish are becoming key human disease models for studying genetics, disease mechanisms, and drug discovery with speed and precision.

How zebrafish in vivo models enhance target validation in drug discovery and support early-stage drug development.

Discover the strengths and limitations of zebrafish, mice, and other model organisms, comparing human gene homology, brood size and life cycle.

Discover how zebrafish preclinical research accelerates drug discovery. Explore 3 key use cases for efficacy, toxicity, and disease modeling.

Zebrafish models enhance hit-to-lead optimization, accelerating early drug development with high-throughput screening.

Learn about zebrafish development, from embryo to larvae. Discover the zebrafish developmental stages and why they’re ideal for biomedical research.

Optimize drug discovery pipelines with zebrafish high-throughput screening. Discover automation, robotics & phenotypic screening solutions.

The Drug Discovery and Development Process: Context and Functions

Exploring how zebrafish screening transformed cardiomyopathy drug development, reducing costs and accelerating timelines

Accelerating Drug Development with Zebrafish Models

Exploring the Benefits of Zebrafish Model in Modern Research

Advancing Drug Discovery with Zebrafish High-Content Screening

Leveraging Zebrafish for Reduction, Refinement, and Replacement in Preclinical Studies

Identifying Successfully Injected Embryos With Fluorescence

How To Do A Microinjection of Zebrafish Embryos?

Proven Techniques for Successful Zebrafish Reproduction and Embryo Collection

Understanding Shared Genes and Their Impact on Human Medicine

What Does Zebrafish Eat? Balancing Nutrition and Convenience with Live and Dry Food

Essential Zebrafish Husbandry Practices for Effective Tank Cleaning and Disinfection

Best Practices for Zebrafish Husbandry: Monitoring Health and Maintaining Rack Systems

Best Practices for Long-Term Zebrafish Care and Husbandry

A Step-by-Step Guide to Establishing a Thriving Zebrafish Colony

Essential Water Quality Tips for Healthy and Thriving Zebrafish

Temperature, pH, Conductivity and Density Guidelines for Zebrafish Husbandry

Understanding Zebrafish Biology and Behavior in Research

From Ornamental Fish to a Cornerstone of Scientific Discovery

Discover how zebrafish accelerate early-stage screening, enhance predictive insights, and reduce costs in drug development

Is the Traditional Drug Discovery Process Holding Back Your Pipeline?

The Impact of AI on Pipelines, Productivity, and Clinical Success

How Does ZeClinics Take Advantage of Data Science?

Leveraging Relationships in Knowledge Graphs to Enhance Drug Discovery and Target Identification

Key Mistakes to Avoid for Successful Zebrafish Genetic Modeling

Evaluating Methods for Precision and Efficiency in Genetic Engineering

Transgenic Animals Meaning + Application Examples

Two Applications of CRISPR/Cas9 Gene Knockout

Readily assess visual function in a live organism

Understanding DNA Repair Pathways

Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0

The use of target gene-editing in preclinical research

The most precise CRISPR to date turns the genetic scissors into a Swiss army knife 

The United States approves technological alternatives to reduce animal testing

What is CRISPR technology and how can change our lives?

Gene editing enables scientists to alter the sequence of genes by adding, replacing, or removing certain DNA segments.

How does genetic information pass down through generations and what errors can occur?

The correspondence between two biological languages

What is the relationship between DNA, RNA and proteins?

Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.

Zebrafish contribution to drug development reaching clinical stages

AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.

Zebrafish for regulatory purposes in ecotoxicology and safety pharmacology

New trends and updated availability for zebrafish studies in EU and US

Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs

How to choose which type of experiment is best-suited for my research?

Use of biomarkers in endocrine disruption compounds screening and testing with zebrafish

Leveraging zebrafish to study Age-related Macular Degeneration

The emerging use of zebrafish to model metabolic diseases

Are zebrafish suitable for human drug discovery?

The regulatory status of zebrafish as an alternative preclinical model.

In ZeClinics we bet on emerging technologies to scale our solutions.

Zebrafish represents a key tool to boost drug discovery by enabling phenotypic screening approach in pharmacological-based disease models.